
Mr Paul Kopp
Stony Brook (United States of America)
Follow
Contributor content
Presentation
Validating prediction models for hypertrophic cardiomyopathy genotype positivity
Presentation
Mavacamten eligibility in an Irish hypertrophic cardiomyopathy cohort
Presentation

